Condition
High-risk Human Papillomavirus Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 2 High-risk Human Papillomavirus Infection clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Italy (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
DARE-HPV: testing a two-dose, two-duration approach to clear persistent hrHPV in women
This trial tests whether DARE-HPV can clear persistent high-risk HPV in premenopausal women aged 22–50, using two doses and two treatment lengths against a placebo.
-
Observing viral biomarkers and microRNAs in oropharyngeal tumors and occult cancers related to HPV
This study is testing if certain viral markers and microRNAs in oropharyngeal tumors can help doctors better diagnose and monitor HPV-related cancers and find new treatments.
Related topics
Quick answers
How many High-risk Human Papillomavirus Infection clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.